In Situ STING-Activating Nanovaccination with TIGIT Blockade for Enhanced Immunotherapy of Anti-PD-1-Resistant Tumors.
Adv Mater
; 35(24): e2300171, 2023 Jun.
Article
in En
| MEDLINE
| ID: mdl-37053496
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Neoplasms
Limits:
Humans
Language:
En
Journal:
Adv Mater
Year:
2023
Document type:
Article